Article: NJ Biotechnology Industry Sees Strong Growth Continuing.

Number of New Jersey Companies Nearly Doubled in Three Years

Increases in Employees, R&D and Revenues; Early Stage Research Funding a Challenge

TRENTON, N.J., June 15 /PRNewswire/ -- New Jersey's biotechnology industry continued to experience strong growth from 2002 to 2005, with the number of employees in publicly held companies growing by 19 percent, research and development at publicly held companies increasing 40 percent to $737 million and revenues for both public and private companies exceeding $2 billion, according to a survey released today by the Biotechnology Council of New Jersey (BCNJ) and Ernst & Young. Conducted by Ernst & Young in the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!